Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis

Journal of Clinical Gastroenterology

Volumn 42, Issue 2, 2008, Pages 208-211

  Lemos, Lara B ^a   Perez, Renata M ^b   Matos, Carla A L ^a   Silva, Ivonete S ^a   Silva, Antonio Eduardo B ^a   Ferraz, Maria Lucia G ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c NONE   (Brazil)

Author keywords

Acute hepatitis C; Anti HCV; End stage renal disease; HCR RNA; Hemodialysis

Indexed keywords

ALANINE AMINOTRANSFERASE;

ACUTE HEPATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; VIREMIA;

ACUTE DISEASE; ADULT; ALANINE TRANSAMINASE; DISEASE PROGRESSION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RNA, VIRAL; TIME FACTORS;

EID: 38349113233     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31802dc57f     Document Type: Article

References (28)

1. Pol S, Vallet-Pichard A, Fontaine H, et al. HCV infection and hemodialysis. Semin Nephrol. 2002;22:331-339.
2. Izopet J, Sandres-Saune K, Kamar N, et al. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol. 2005;77:70-76.
3. Hinrichsen H, Leimenstoll G, Stegen G, et al. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut. 2002;51:429-433.
4. Jadoul M, Cornu C, van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int. 1993;44:1322-1326.
5. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis. 1995;15:5-14.
6. Zampieron A, Jayasekera H, Elseviers M, et al. European study on epidemiology and management of hepatitis C virus (HCV) infection in the haemodialysis population. Part 3: prevalence and incidence. Edtna Erca J. 2006;32:42-44.
7. Cendoroglo Neto M, Manzano SI, Canziani ME, et al. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs. 1995;19:251-255.
8. Okuda K, Hayashi H, Kobayashi S, et al. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol. 1995;23:28-31.
9. Sampietro M, Badalamenti S, Salvadori S, et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int. 1995;47:911-917.
10. Izopet J, Pasquier C, Sandres K, et al. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol. 1999;58:139-144.
11. Froio N, Nicastri E, Comandini UV, et al. Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis. 2003;42:546-550.
12. Furusyo N, Kubo N, Nakashima H, et al. Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit. Infect Control Hosp Epidemiol. 2004;25:584-590.
13. Hmaied F, Ben Mamou M, Saune-Sandres K, et al. Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission. J Med Virol. 2006;78:185-191.
14. Fabrizi F, de Vecchi AF, Como G, et al. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Aliment Pharmacol Ther. 2005;21:861-869.
15. Arenas MD, Sanchez-Paya J, Munoz C, et al. Nosocomial transmission of the hepatitis C virus in hemodialysis: monitors, personnel, or both?. Nefrologia. 2001;21:476-484.
16. Saxena AK, Panhotra BR, Sundaram DS, et al. Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the middle east. Am J Infect Control. 2003;31:26-33.
17. Perez RM, Ferraz ML, Figueiredo MS, et al. Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients. J Med Virol. 2003;69:489-494.
18. Furusyo N, Hayashi J, Kakuda K, et al. Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study. Am J Gastroenterol. 2001;96:1592-1600.
19. Okuda K, Hayashi H, Yokozeki K, et al. Acute hepatitis C among renal failure patients on chronic haemodialysis. J Gastroenterol Hepatol. 1998;13:62-67.
20. Espinosa M, Martin-Malo A, Alvarez de Lara MA, et al. Natural history of acute HCV infection in hemodialysis patients. Clin Nephrol. 2002;58:143-150.
21. Simjanovska LJ, Porcu K, Amitov V, et al. Reverse transcriptase/ polymerase chain reaction analyses of hemodialysis ultrafiltrates and sera of hepatitis C virus positive patients. Int J Artif Organs. 2004;27:35-39.
22. Leads from the MMWR. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. JAMA. 1988;260:462-465.
23. Guh JY, Lai YH, Yang CY, et al. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron. 1995;69:459-465.
24. Yasuda K, Okuda K, Endo N, et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology. 1995;109:1295-1300.
25. Uyttendaele S, Claeys H, Mertens W, et al. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang. 1994;66:122-129.
26. Fabrizi F, Lunghi G, Raffaele L, et al. Serologic survey for control of hepatitis C in haemodialysis patients: third-generation assays and analysis of costs. Nephrol Dial Transplant. 1997;12:298-303.
27. Busch MP, Tobler LH, Tegtmeier G, et al. Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback. Transfusion. 2000;40:10-14.
28. Moreira R, Pinho JR, Fares J, et al. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol. 2003;49:503-507.